COVID-19 and Diabetes

Diabetes mellitus patients are more likely to develop coronavirus disease 2019 (COVID-19), which is caused by infection with the severe acute respiratory syndrome coronavirus 2. COVID-19 may increase the risk of hyperglycemia in infected individuals. When combined with other risk factors, hyperglycemia may modulate immunological and inflammatory responses, predisposing individuals to severe COVID-19 and potentially fatal outcomes. Patients with diabetes should be aware that COVID-19 can raise blood glucose levels, so they should follow clinical guidelines for diabetes management more closely during the treatment period as:

  • Controlling glucose levels in pandemic
  • Inflammation and diabetes
  • Immunology and diabetes
  • Diabetes after COVID-19 positive

    Related Conference of COVID-19 and Diabetes

    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    4th International Summit on Hormonal Disorders

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Aix-en-Provence, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Aix-en-Provence, France

    COVID-19 and Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in